Korean Drug Co. Ltd (014570) — Cash Flow Reinvestment Rate
Korean Drug Co. Ltd (014570) has a Cash Flow Reinvestment Rate of 0.02x as of June 2026, reinvesting ₩32.89 Million (capex ₩17.20 Million plus investments ₩15.69 Million) from operating cash flow of ₩1.90 Billion. See Korean Drug Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Korean Drug Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Korean Drug Co. Ltd.
Annual Cash Flow Reinvestment Rate for Korean Drug Co. Ltd (2014–2025)
Year-by-year capital reinvestment analysis for Korean Drug Co. Ltd. See 014570 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.81x | ₩10.66 Billion | ₩13.11 Billion | ₩475.05 Million | ▼ -66.8% |
| 2024 | 2.45x | ₩11.93 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +107.4% |
| 2022 | 1.18x | ₩6.99 Billion | ₩5.91 Billion | ₩6.09 Billion | ▲ +28.1% |
| 2021 | 0.92x | ₩8.13 Billion | ₩8.81 Billion | ₩1.15 Billion | ▲ +6.8% |
| 2020 | 0.86x | ₩10.65 Billion | ₩12.33 Billion | ₩738.47 Million | ▲ +27.3% |
| 2019 | 0.68x | ₩4.21 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +19.6% |
| 2018 | 0.57x | ₩3.28 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -88.1% |
| 2017 | 4.78x | ₩2.14 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +1240.0% |
| 2016 | 0.36x | ₩1.41 Billion | ₩3.96 Billion | ₩460.84 Million | ▲ +21.1% |
| 2015 | 0.29x | ₩1.81 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +143.8% |
| 2014 | 0.12x | ₩539.06 Million | ₩4.46 Billion | ₩538.19 Million | — |